Fifth Third Bancorp
RVMD icon

Fifth Third Bancorp’s Revolution Medicines RVMD Stock Holding History

Fifth Third Bancorp’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$492K Sell
2,625
-7,083
-73% -$1.03M ﹤0.01% 2108
2026
Q1 		$944K Buy
9,708
+9,601
+8,973% +$969K ﹤0.01% 1672
2025
Q4 		$8.52K Buy
107
+88
+463% +$5.77K ﹤0.01% 2176
2025
Q3 		$887 Sell
19
-5
-21% -$196 ﹤0.01% 2542
2025
Q2 		$883 Buy
24
+14
+140% +$538 ﹤0.01% 2443
2025
Q1 		$354 Sell
10
-9
-47% -$365 ﹤0.01% 2465
2024
Q4 		$831 Sell
19
-14
-42% -$707 ﹤0.01% 2422
2024
Q3 		$1.5K Buy
+33
New +$1.44K ﹤0.01% 2388

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Fifth Third Bancorp's RVMD Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Revolution Medicines (RVMD) stake by 73% in Q2 2026, selling an estimated $1.03M and leaving 2,625 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

Fifth Third Bancorp first reported a position in RVMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $944K in Q1 2026. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Fifth Third Bancorp held 2,625 shares of Revolution Medicines worth $492K as of Q2 2026.
  • Fifth Third Bancorp sold 7,083 Revolution Medicines shares in Q2 2026, an estimated $1.03M.
  • Revolution Medicines made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2108 holding.
  • Fifth Third Bancorp first reported a position in Revolution Medicines in Q3 2024 and has held it in 8 quarters since.
  • Fifth Third Bancorp's Revolution Medicines position peaked at $944K in Q1 2026.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.